LB Group Inkomsten in het verleden
Verleden criteriumcontroles 5/6
LB Group has been growing earnings at an average annual rate of 4.9%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 18.9% per year. LB Group's return on equity is 13.5%, and it has net margins of 13.2%.
Belangrijke informatie
4.9%
Groei van de winst
1.4%
Groei van de winst per aandeel
Chemicals Groei van de industrie | 12.1% |
Inkomstengroei | 18.9% |
Rendement op eigen vermogen | 13.5% |
Nettomarge | 13.2% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe LB Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 27,370 | 3,607 | 1,575 | 783 |
30 Jun 24 | 27,309 | 3,645 | 1,570 | 789 |
31 Mar 24 | 27,080 | 3,557 | 1,678 | 918 |
31 Dec 23 | 26,765 | 3,185 | 1,594 | 1,014 |
30 Sep 23 | 26,345 | 2,263 | 1,855 | 1,145 |
30 Jun 23 | 24,961 | 2,290 | 1,805 | 1,177 |
31 Mar 23 | 25,018 | 2,809 | 1,821 | 1,068 |
01 Jan 23 | 24,113 | 3,294 | 1,866 | 1,014 |
30 Sep 22 | 23,327 | 4,019 | 1,850 | 1,263 |
30 Jun 22 | 23,128 | 4,508 | 1,882 | 1,246 |
31 Mar 22 | 21,989 | 4,677 | 1,840 | 1,165 |
01 Jan 22 | 20,566 | 4,676 | 1,619 | 1,010 |
30 Sep 21 | 19,480 | 4,170 | 1,074 | 826 |
30 Jun 21 | 17,623 | 3,431 | 925 | 664 |
31 Mar 21 | 15,066 | 2,451 | 842 | 530 |
31 Dec 20 | 14,112 | 2,289 | 964 | 539 |
30 Sep 20 | 12,989 | 2,478 | 1,204 | 491 |
30 Jun 20 | 12,326 | 2,617 | 1,199 | 457 |
31 Mar 20 | 12,274 | 2,872 | 1,169 | 425 |
31 Dec 19 | 11,362 | 2,594 | 1,044 | 416 |
30 Sep 19 | 10,691 | 2,381 | 1,084 | 465 |
30 Jun 19 | 10,546 | 2,215 | 1,087 | 468 |
31 Mar 19 | 10,674 | 2,311 | 1,084 | 448 |
31 Dec 18 | 10,444 | 2,286 | 1,058 | 399 |
30 Sep 18 | 10,731 | 2,552 | 941 | 445 |
30 Jun 18 | 10,559 | 2,533 | 786 | 599 |
31 Mar 18 | 10,456 | 2,515 | 927 | 495 |
31 Dec 17 | 10,258 | 2,502 | 952 | 419 |
30 Sep 17 | 9,657 | 2,243 | 979 | 270 |
30 Jun 17 | 7,797 | 1,681 | 981 | 0 |
31 Mar 17 | 5,857 | 1,011 | 681 | 0 |
31 Dec 16 | 4,136 | 442 | 561 | 0 |
30 Sep 16 | 2,767 | 172 | 322 | 0 |
30 Jun 16 | 2,612 | 136 | 297 | 0 |
31 Mar 16 | 2,644 | 114 | 298 | 0 |
31 Dec 15 | 2,635 | 111 | 295 | 0 |
30 Sep 15 | 2,370 | 96 | 282 | 0 |
30 Jun 15 | 2,324 | 98 | 289 | 0 |
31 Mar 15 | 2,265 | 76 | 269 | 0 |
31 Dec 14 | 2,051 | 63 | 240 | 0 |
30 Sep 14 | 2,015 | 39 | 247 | 0 |
30 Jun 14 | 1,981 | 34 | 217 | 0 |
31 Mar 14 | 1,746 | 19 | 184 | 0 |
31 Dec 13 | 1,723 | 24 | 167 | 0 |
Kwaliteitswinsten: 002601 has high quality earnings.
Groeiende winstmarge: 002601's current net profit margins (13.2%) are higher than last year (8.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 002601's earnings have grown by 4.9% per year over the past 5 years.
Versnelling van de groei: 002601's earnings growth over the past year (59.4%) exceeds its 5-year average (4.9% per year).
Winst versus industrie: 002601 earnings growth over the past year (59.4%) exceeded the Chemicals industry -3.8%.
Rendement op eigen vermogen
Hoge ROE: 002601's Return on Equity (13.5%) is considered low.